GSA Capital Partners LLP bought a new position in Wright Medical Group NV (NASDAQ:WMGI) in the third quarter, HoldingsChannel reports. The firm bought 63,018 shares of the medical device company’s stock, valued at approximately $1,829,000.
Several other hedge funds also recently bought and sold shares of WMGI. Principal Financial Group Inc. raised its holdings in Wright Medical Group by 7.0% in the 1st quarter. Principal Financial Group Inc. now owns 92,781 shares of the medical device company’s stock worth $1,841,000 after purchasing an additional 6,084 shares during the period. Amalgamated Bank raised its holdings in Wright Medical Group by 14.9% in the 2nd quarter. Amalgamated Bank now owns 16,232 shares of the medical device company’s stock worth $421,000 after purchasing an additional 2,102 shares during the period. Aperio Group LLC acquired a new position in shares of Wright Medical Group during the second quarter valued at approximately $364,000. Los Angeles Capital Management & Equity Research Inc. acquired a new position in shares of Wright Medical Group during the second quarter valued at approximately $362,000. Finally, Sivik Global Healthcare LLC acquired a new position in shares of Wright Medical Group during the second quarter valued at approximately $2,204,000.
In other news, Director Elizabeth H. Weatherman sold 15,949 shares of the firm’s stock in a transaction on Monday, November 19th. The stock was sold at an average price of $28.63, for a total transaction of $456,619.87. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Peter Cooke sold 13,478 shares of the firm’s stock in a transaction on Friday, November 2nd. The stock was sold at an average price of $28.03, for a total value of $377,788.34. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 67,466 shares of company stock valued at $1,962,392. Company insiders own 4.00% of the company’s stock.
WMGI opened at $28.04 on Tuesday. Wright Medical Group NV has a 52 week low of $19.01 and a 52 week high of $30.75. The firm has a market cap of $3.50 billion, a PE ratio of -127.45 and a beta of 1.15. The company has a quick ratio of 1.07, a current ratio of 1.24 and a debt-to-equity ratio of 0.61.
Wright Medical Group (NASDAQ:WMGI) last released its quarterly earnings results on Wednesday, November 7th. The medical device company reported ($0.09) EPS for the quarter, topping the consensus estimate of ($0.15) by $0.06. Wright Medical Group had a negative return on equity of 0.60% and a negative net margin of 13.07%. The business had revenue of $194.11 million during the quarter, compared to analyst estimates of $186.09 million. During the same period last year, the business posted ($0.16) earnings per share. The company’s quarterly revenue was up 13.8% on a year-over-year basis. Equities research analysts predict that Wright Medical Group NV will post -0.07 earnings per share for the current fiscal year.
About Wright Medical Group
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells extremities and biologics products. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth.
Featured Article: What is a Stop Order?
Want to see what other hedge funds are holding WMGI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Wright Medical Group NV (NASDAQ:WMGI).
Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.